Monday, July 22, 2024
JPA Health has acquired London’s akt health communications, which has 23 staffers, to expand the European capabilities of the Washington-based firm.
akt founders Anna Radnavale, Katy Foy and Tim Cockroft have joined JPA as executive directors.
The British shop handles high-profile clients such as Bristol Myers Squibb, GSK, Gilead, Chiesi, Takeda, ucbPharma, Alnylam Pharmaceuticals, and the UK National Health Service.
JPA CEO Carrie Jones said akt’s deep understanding of the complexities of the European market will enhance her firm’s ability to deliver impactful healthcare solutions on a global scale.
The combined company has about 150 staffers offering corporate communications, brand marketing, patient engagement and scientific storytelling.
The akt deal follows JPA’s acquisitions of BioCentric (clinical communications firm) in May, and True North Solutions (commercial, clinical and medical affairs shop) in October 2023.
JPA took the No. 12 slot in O’Dwyer’s healthcare rankings with fee income of $24.3M during the past year.